Global Atopic Dermatitis Drugs Market Size & Outlook
Global atopic dermatitis drugs market, 2018-2030 (US$M)
Related Markets
Global atopic dermatitis drugs market highlights
- The global atopic dermatitis drugs market generated a revenue of USD 17,637.9 million in 2024 and is expected to reach USD 29,879.5 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 9% by 2030.
- In terms of segment, biologics accounted for a revenue of USD 7,935.0 million in 2024.
- PDE4 Inhibitors is the most lucrative drug class segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 17,637.9 million |
| Market revenue in 2030 | USD 29,879.5 million |
| Growth rate | 9% (CAGR from 2025 to 2030) |
| Largest segment | Biologics |
| Fastest growing segment | PDE4 Inhibitors |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Corticosteroids, Calcineurin Inhibitors, PDE4 Inhibitors, Biologics |
Other key industry trends
- In terms of revenue, the North America accounted for 45.1% of the global atopic dermatitis drugs market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, China is the fastest growing regional market and is projected to reach USD 1,021.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Atopic Dermatitis Drugs Market Scope
Atopic Dermatitis Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global atopic dermatitis drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to atopic dermatitis drugs market will help companies and investors design strategic landscapes.
Biologics was the largest segment with a revenue share of 44.99% in 2024. Horizon Databook has segmented the Global atopic dermatitis drugs market based on corticosteroids, calcineurin inhibitors, pde4 inhibitors, biologics covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Atopic Dermatitis Drugs Drug Class Outlook (Revenue, USD Million, 2018-2030)
- Corticosteroids
- Calcineurin Inhibitors
- Others
- PDE4 Inhibitors
- Biologics
- Global Atopic Dermatitis Drugs Route of Administration Outlook (Revenue, USD Million, 2018-2030)
- Topical
- Parenteral
- Oral
- Global Atopic Dermatitis Drugs Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Hospital Pharmacies
- Retail Pharmacies
- Others
Reasons to subscribe to Global atopic dermatitis drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global atopic dermatitis drugs market databook
-
Our clientele includes a mix of atopic dermatitis drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global atopic dermatitis drugs market , including forecasts for subscribers. This global databook contains high-level insights into Global atopic dermatitis drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global atopic dermatitis drugs market size, by regions, 2018-2030 (US$M)
Top 10 countries: Atopic dermatitis drugs market size, 2024 (US$M)
Global atopic dermatitis drugs market share, by drug class, 2024 & 2030 (%, US$M)
Atopic dermatitis drugs market: Opportunity assessment by country
Global atopic dermatitis drugs market, by region, 2024 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
